PRF Technologies (PRFX) Change in Account Payables (2020 - 2024)

PRF Technologies (PRFX) posted quarterly Change in Account Payables of -$761000.0 for Q2 2024, down 1327.42% year-on-year from $62000.0 in Q3 2023, and down 189.01% on a QoQ basis from $855000.0 in Q1 2024.

PRF Technologies (PRFX) Change in Account Payables (2020 - 2024) Analysis & Trends

PRF Technologies (PRFX) has reported Change in Account Payables for 5 consecutive years, with -$761000.0 the latest figure, recorded in Q2 2024.

  • Quarterly Change in Account Payables fell 1327.42% year-over-year to -$761000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$30000.0 (down 105.41% YoY) and the FY2024 annual result came in at $91000.0, up 78.43% from the prior year.
  • Change in Account Payables declined to -$761000.0 in Q2 2024 per PRFX's latest filing, from $855000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for PRFX reached as high as $855000.0 in Q1 2024 and fell as low as -$761000.0 in Q2 2024.
  • A 5-year average of $60529.4 and a median of $62000.0 in 2023 frame the typical range for Change in Account Payables.
  • The largest YoY upside for Change in Account Payables was 656.64% in 2024 against a maximum downside of 1327.42% in 2024.
  • Year by year, Change in Account Payables stood at $172000.0 in 2020, then dropped by 1.16% to $170000.0 in 2021, then surged by 178.82% to $474000.0 in 2022, then slumped by 84.39% to $74000.0 in 2023, then slumped by 1128.38% to -$761000.0 in 2024.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$761000.0, $855000.0, and $74000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 PRF Technologies 745,168.93 451,168.93 - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -761,000.00
Jun 30, 2024 -761,000.00
Mar 31, 2024 855,000.00
Mar 31, 2024 855,000.00
Dec 31, 2023 74,000.00
Dec 31, 2023 74,000.00
Sep 30, 2023 -198,000.00
Sep 30, 2023 -198,000.00
Jun 30, 2023 62,000.00
Jun 30, 2023 62,000.00
Mar 31, 2023 113,000.00
Mar 31, 2023 113,000.00
Sep 30, 2022 474,000.00
Sep 30, 2022 474,000.00
Jun 30, 2022 -94,000.00
Jun 30, 2022 -94,000.00
Mar 31, 2022 -186,000.00
Mar 31, 2022 -186,000.00
Dec 31, 2021 170,000.00
Dec 31, 2021 170,000.00